Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits

Background: Myanmar has set national hepatitis C (HCV) targets to achieve 50% of people diagnosed and 50% treated by 2030. The WHO has additional targets of reducing incidence by 80% and mortality by 65% by 2030. We aimed to estimate the impact, cost, cost-effectiveness and net economic benefit of a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nick Scott, Thin Mar Win, Tom Tidhar, Hla Htay, Bridget Draper, Phyo Thu Zar Aung, Yinzong Xiao, Anna Bowring, Christian Kuschel, Sonjelle Shilton, Khin Pyone Kyi, Win Naing, Khin Sanda Aung, Margaret Hellard
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2021-05-01
coleção:	The Lancet Regional Health. Western Pacific
Assuntos:	Elimination Hepatitis C Low and middle income country Mathematical model Myanmar
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666606521000389
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!